Case report: complete long-lasting response to multimodal third line treatment with neurosurgical resection, carmustine wafer implantation and dabrafenib plus trametinib in a BRAFV... von Castelli, Barbara, Tellini, Marco, Guidi, Melina, Di Nicola, Marco, Giunti, Laura, Buccoliero, Anna Maria, Censullo, Maria Luigia, Iacono, Alessandro, Desideri, Isacco, Genitori, Lorenzo, Sardi, Iacopo, Fonte, Carla

Volltext

Case report: complete long-lasting response to multimodal third line treatment with neurosurgical resection, carmustine wafer implantation and dabrafenib plus trametinib in a BRAFV... von Castelli, Barbara, Tellini, Marco, Guidi, Melina, Di Nicola, Marco, Giunti, Laura, Buccoliero, Anna Maria, Censullo, Maria Luigia, Iacono, Alessandro, Desideri, Isacco, Genitori, Lorenzo, Sardi, Iacopo, Fonte, Carla

Volltext

OC1.02.5 LONG-TERM SCHEDULED THERAPY WITH INFLIXIMAB IN INFLAMMATORY BOWEL DISEASE von Armuzzi, A, De Vincentis, F, Marzo, M, De Pascalis, B, Roberto, I, Mocci, G, Fiore, F, Leso, V, Fedeli, P, Papa, A, De Vitis, I, Melina, D, Fedeli, G, Gasbarrini, A, Guidi, L

Volltext

Safety profile of infliximab in inflammatory bowel disease: Single-center experience in 102 patients and 672 infusions von Armuzzi, A., Guidi, L., De Pascalis, B., Roberto, I., Lupascu, A., De Vitis, I., Papa, A., Mentella, M.C., Danese, S., Fedeli, P., Melina, D., Fedeli, G., Gasbarrini, G., Gasbarrini, A.

Volltext